These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32222766)

  • 1. Resist the Temptation of Response-Adaptive Randomization.
    Proschan M; Evans S
    Clin Infect Dis; 2020 Dec; 71(11):3002-3004. PubMed ID: 32222766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints.
    Cao W; Zhu H; Wang L; Zhang L; Yu J
    Stat Med; 2024 Apr; 43(9):1743-1758. PubMed ID: 38387866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends with response-adaptive randomization: The inevitability of inefficiency.
    Korn EL; Freidlin B
    Clin Trials; 2022 Apr; 19(2):158-161. PubMed ID: 34991348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity.
    Xu Z; Ma T; Tang L; Talisa VB; Chang CH
    Stat Med; 2024 Mar; 43(6):1256-1270. PubMed ID: 38258898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Bayesian adaptive randomization procedures with adaptive clip methods for multi-arm trials.
    May Lee K; Lee JJ
    Stat Methods Med Res; 2021 May; 30(5):1273-1287. PubMed ID: 33689524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    J Biopharm Stat; 2020; 30(1):69-88. PubMed ID: 31017843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical response adaptive block randomization (RABR) design with analytic type I error protection.
    Zhan T; Cui L; Geng Z; Zhang L; Gu Y; Chan ISF
    Stat Med; 2021 Oct; 40(23):4947-4960. PubMed ID: 34111902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials.
    Granholm A; Kaas-Hansen BS; Lange T; Schjørring OL; Andersen LW; Perner A; Jensen AKG; Møller MH
    J Clin Epidemiol; 2023 Jan; 153():45-54. PubMed ID: 36400262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.